Metis Global Partners’s Organogenesis Holdings ORGO Stock Holding History

Metis Global Partners’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.9K	Hold	17,237	–	–	﹤0.01%	713
2026 Q1	$40.9K	Sell	17,237 -12,082	-41%	-$41.9K	﹤0.01%	724
2025 Q4	$152K	Hold	29,319	–	–	﹤0.01%	747
2025 Q3	$124K	Hold	29,319	–	–	﹤0.01%	751
2025 Q2	$107K	Hold	29,319	–	–	﹤0.01%	757
2025 Q1	$127K	Hold	29,319	–	–	﹤0.01%	768
2024 Q4	$93.8K	Hold	29,319	–	–	﹤0.01%	776
2024 Q3	$83.9K	Buy	+29,319	New	+$82.2K	﹤0.01%	777

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Metis Global Partners's ORGO Position: Q2 2026 in Review

Metis Global Partners held its Organogenesis Holdings (ORGO) position steady in Q2 2026 at 17,237 shares worth $41.9K. The position accounts for ﹤0.01% of the portfolio, ranked #713.

Metis Global Partners first reported a position in ORGO in Q3 2024 and has held it in 8 quarters since. The position peaked at $152K in Q4 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

Metis Global Partners held 17,237 shares of Organogenesis Holdings worth $41.9K as of Q2 2026.
Metis Global Partners left its Organogenesis Holdings share count unchanged in Q2 2026.
Organogenesis Holdings made up ﹤0.01% of Metis Global Partners's portfolio in Q2 2026, its #713 holding.
Metis Global Partners first reported a position in Organogenesis Holdings in Q3 2024 and has held it in 8 quarters since.
Metis Global Partners's Organogenesis Holdings position peaked at $152K in Q4 2025.
134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.